Physician profile
Michael Gooch
NPI 1548587884
$54,890.53
in general payments reported to CMS, 2019-2025
13 companies · $6,594 in 2025
The $6,594 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,042 · 2020: $16K · 2021: $11K · 2022: $17K · 2023: $2,290 · 2024: $482 · 2025: $6,594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,480 · Food and Beverage: $1,755 · Travel and Lodging: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,479.97 |
| Food and Beverage | $1,755.15 |
| Travel and Lodging | $1,131.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $34,818.71 | 2019-2024 | Surpass Evolve |
| Rapid Medical LTD | $10,259.13 | 2022-2024 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Microtransponder, INC. | $4,259.19 | 2023-2025 | |
| Medtronic, INC. | $2,572.07 | 2021-2025 | Pipeline, Onyx 18, Vanta Adaptivestim |
| Ge Healthcare | $1,602.65 | 2019 | |
| Irras USA, INC. | $695.52 | 2022-2024 | |
| Depuy Synthes Sales INC. | $202.70 | 2022-2023 | Embotrap |
| Penumbra, INC. | $149.76 | 2019 | |
| Microvention, INC. | $148.06 | 2019-2023 | Web Aneurysm Embolization System |
| Route 92 Medical, INC. | $75.53 | 2024 | 8f Base Camp Sheath System |
| Boston Scientific Corporation | $60.45 | 2025 | General - Dbs |
| Medtronic USA, INC. | $28.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gooch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.